- Home
- PSQH vs BCAB Comparison
PSQH vs BCAB Comparison
Compare PSQH & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSQH | BCAB |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.4M | 71.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PSQH | BCAB |
|---|---|---|
| Price | $1.09 | $0.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $6.00 | $1.00 |
| AVG Volume (30 Days) | 596.7K | ★ 1.1M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,534,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 196.08 | N/A |
| 52 Week Low | $0.92 | $0.24 |
| 52 Week High | $5.18 | $1.43 |
Technical Indicators
Market Signals| Indicator | PSQH | BCAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.88 | 51.54 |
| Support Level | $1.07 | $0.63 |
| Resistance Level | $1.22 | $0.83 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 31.58 | 73.41 |
Price Performance
Historical ComparisonAbout PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.